As of 2025-09-17, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (69.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.29 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -1200.5%.
The range of the Relative Valuation is (58.81) - (71.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (58.81) - (71.76) | (69.22) |
| Upside | -1034.9% - -1240.8% | -1200.5% |
| Date | P/E |
| 2025-09-17 | -1.78 |
| 2025-09-16 | -1.80 |
| 2025-09-15 | -1.81 |
| 2025-09-12 | -1.87 |
| 2025-09-11 | -1.89 |
| 2025-09-10 | -1.85 |
| 2025-09-09 | -1.95 |
| 2025-09-08 | -1.95 |
| 2025-09-05 | -2.00 |
| 2025-09-04 | -1.97 |
| 2025-09-03 | -2.21 |
| 2025-09-02 | -2.14 |
| 2025-08-29 | -2.15 |
| 2025-08-28 | -2.17 |
| 2025-08-27 | -2.27 |
| 2025-08-26 | -2.18 |
| 2025-08-25 | -2.18 |
| 2025-08-22 | -2.34 |
| 2025-08-21 | -2.19 |
| 2025-08-20 | -2.13 |
| 2025-08-19 | -2.17 |
| 2025-08-18 | -2.27 |
| 2025-08-15 | -2.19 |
| 2025-08-14 | -2.17 |
| 2025-08-13 | -2.18 |
| 2025-08-12 | -2.08 |
| 2025-08-11 | -2.03 |
| 2025-08-08 | -2.08 |
| 2025-08-07 | -2.01 |
| 2025-08-06 | -2.25 |
| 2025-08-05 | -2.31 |
| 2025-08-04 | -2.27 |
| 2025-08-01 | -2.19 |
| 2025-07-31 | -2.22 |
| 2025-07-30 | -2.33 |
| 2025-07-29 | -2.38 |
| 2025-07-28 | -2.35 |
| 2025-07-25 | -2.34 |
| 2025-07-24 | -2.38 |
| 2025-07-23 | -2.38 |
| 2025-07-22 | -2.32 |
| 2025-07-21 | -2.15 |
| 2025-07-18 | -2.15 |
| 2025-07-17 | -2.22 |
| 2025-07-16 | -2.19 |
| 2025-07-15 | -2.13 |
| 2025-07-14 | -2.25 |
| 2025-07-11 | -2.20 |
| 2025-07-10 | -2.24 |
| 2025-07-09 | -2.23 |